BCL6 and neoplasm: The abundance of Bcl6+CD11b+F4/80+Ly6C− SMMs in tumor tissues correlates with advanced tumor stage, increased metastasis, and poor overall survival in patients with colorectal cancer, breast cancer, and glioblastoma [139].